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INTRODUCTION:  Acinetobacter  baumannii  is  usually  associated  with  respiratory  tract,  urinary  tract  and
bloodstream  infections.  Recent  reports  suggest  that  it is increasingly  causing  skin  and  soft tissue  infec-
tions.  It is also evolving  as a multidrug  resistant  organism  that can  be difﬁcult  to treat.  We present  a  fatal
case of multidrug  resistant  A. baumannii  soft tissue  infection  and  review  of  relevant  literature.
PRESENTATION  OF  CASE:  A  41  year  old morbidly  obese  man,  with  history  of alcoholic  liver disease  pre-
sented  with  left  superﬁcial  pre-tibial  abrasions  and cellulitis  caused  by multidrug  resistant  (MDR)  A.
baumannii.  In spite  of early  antibiotic  administration  he  developed  extensive  myositis  and  fat  necrosis
requiring  extensive  and  multiple  surgical  debridements.  He  deteriorated  despite  appropriate  antibiotic
therapy  and multiple  surgical  interventions  with  development  of  multi-organ  failure  and  died.
DISCUSSION:  Managing  Acinetobacter  infections  remains  difﬁcult  due to the  array  of resistance  and  the
pathogens  ability  to  develop  new  and  ongoing  resistance.  The  early  diagnosis  of  necrotizing  soft  tissue
infection  may  be  challenging,  but  the key  to  successful  management  of  patients  with  necrotizing  soft
tissue  infection  are  early  recognition  and  complete  surgical  debridement.
CONCLUSION:  A.  baumannii  is emerging  as  an  important  cause  of  severe,  life-threatening  soft tissue  infec-
tions. Multidrug  resistant  A.  baumannii  soft  tissue  infections  may  carry  a high  mortality  in spite  of  early
and  aggressive  treatment.  Clinicians  need  to consider  appropriate  early  empirical  antibiotic  coverage  or
the use  of combination  therapy  to include  MDR  A.  baumannii  as  a cause  of  skin  and  soft  tissue  infections.
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. Introduction
Acinetobacter baumannii (A. baumannii)  was ﬁrst described as
 distinct species within the genus Acinetobacter in 1986,1 and is
ften associated with pneumonia, urinary tract and bloodstream
nfections.2 There have also been previously reported cases of multi
rug resistant A. baumannii infections in intensive care units.3 Once
onsidered a rare presentation, A. baumannii is now emerging as an
mportant opportunistic multi drug-resistant (MDR) pathogen of
kin and soft tissue infections (SSTI).4
The management of A. baumannii associated infections is
ncreasingly difﬁcult as a result of increasing rates of antimicrobial
esistance.3 Clinicians need to consider appropriate early empiri-
al antibiotic coverage or the use of combination therapy to include
DR  A. baumannii as a cause of SSTI. We  describe a fatal case of a
atient with MDR  A. baumannii SSTI.∗ Corresponding author. Tel.: +61 4 3127 9347; fax: +61 3 9784 7398.
E-mail addresses: aqsa.aali@gmail.com (A. Ali), JBotha@phcn.vic.gov.au
J. Botha), travindranath@hotmail.com (R. Tiruvoipati).
ttp://dx.doi.org/10.1016/j.ijscr.2014.04.019
210-2612/Crown Copyright © 2014 Published by Elsevier Ltd. on behalf of Surgical
http://creativecommons.org/licenses/by-nc-nd/3.0/).lished  by  Elsevier  Ltd. on  behalf  of Surgical  Associates  Ltd.  This  is  an  open
 BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
2. Case report
A 41 year old morbidly obese man  was  referred by his local
medical ofﬁcer to the emergency department with painful bilateral
oedema of his lower legs and generalized abdominal pain. He had a
past medical history of liver cirrhosis secondary to years of exces-
sive alcohol abuse and hepatitis C infection with the complications
of portal hypertension and oesophageal varices.
On examination he was febrile (37.6 ◦C) with signiﬁcant bilat-
eral pitting oedema and superﬁcial pre-tibial abrasions were noted
over his left leg. The capillary reﬁll time was  normal and the
distal pulses were present in both lower limbs. His abdominal,
respiratory, cardiovascular and neurological examinations were
unremarkable. Baseline investigations revealed a low haemoglobin
of 11.2 g/dl, platelet count of 44 × 109/l, albumin 19 g/l and an
elevated bilirubin 36 mol/l, CRP 37.mg/l, INR 2.1 and lactate of
8.6 mmol/l. Liver enzymes were at the upper limits of normal. On
clinical and biochemical assessment of his liver cirrhosis using the
Child’s Classiﬁcation of liver cirrhosis he was classiﬁed as a Child’s
B case of cirrhosis. Blood cultures and a swab of the left leg were
performed and treatment was  empirically started with intravenous
ﬂucloxacillin and benzylpenicillin for suspected cellulitis.
On the second day of admission his left leg demonstrated sig-
niﬁcantly more swelling than his right, with the overlying skin
 Associates Ltd. This is an open access article under the CC BY-NC-ND license
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F old patient. This was initially presented as superﬁcial pre-tibial abrasions and swelling of
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Fig. 4. Surgical debridement.igs. 1–3. Cellulitis caused by A. baumannii on the left leg and forefoot of a 41 year 
he  lower limb, progressing to bacteraemia and extensive cellulitis and myositis.
rythematous and tender to touch with evidence of induration
nd blistering. The CRP increased to 101.7 mg/l, and intravenous
iproﬂoxacin and cephazolin was commenced for worsening cel-
ulitis.
A left leg duplex ultrasound revealed severe oedema below the
nee and a large knee joint effusion but no evidence of deep vein
hrombosis within the femoral or popliteal veins. A CT scan of his
egs conﬁrmed bilateral knee joint effusions with non-speciﬁc syn-
vitis. There was no evidence of necrotizing fasciitis.
Two consecutive blood cultures grew A. baumannii,  with
ulti drug resistance to amoxicillin, amoxicillin/clavulanate, cef-
riaxone and ceftazidime. It was sensitive to co-trimoxazole,
entamycin, meropenem, ciproﬂoxacin, and ticarcillin/clavulanate.
is antibiotic regime was changed to intravenous meropenem and
ancomycin to cover A. baumannii and also to cover the possibil-
ty of a potential co-pathogen Methicillin-Resistant Staphylococcus
ureus (MRSA).
Conservative management of the lower limbs with leg elevation
nd compression bandages continued and he was  referred to the
econstructive and orthopaedic surgeons for the evaluation of sep-
ic arthritis, a suspected compartment syndrome and exclusion of
ecrotizing fasciitis.
On the third day an MRI  scan of his lower legs revealed extensive
ubcutaneous oedema of the left leg, mild to moderate subcuta-
eous oedema of the right leg, moderate bilateral joint effusions,
ellulitic changes and extensive myositis of the left leg with pos-
ible fasciitis raising the suspicion of compartment syndrome.
espite the MRI  changes the reconstructive surgeons did not
elieve that the clinical evidence for compartment syndrome was
trong enough to require immediate surgical intervention. His left
eg remained erythematous, bullous, and blistering secondary to
he oedema and lincomycin was added as therapy on the recom-
endation of the reconstructive surgeons.
On the fourth day of admission he spiked a fever of 38.4 ◦C
espite continuous broad spectrum antibiotic treatment and the
eft leg was surgically explored (Figs. 1–3). After general anaesthe-
ia and application of a leg tourniquet a longitudinal incision was
ade in the mid  lateral line. At surgery it was documented that
here was no evidence of necrotizing fasciitis and no evidence of
ompartment syndrome in the lateral or anterior compartments.
here was no evidence of an abscess or drainable collection but Fig. 5. The limb after extensive debridement.
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in bacteraemia, extensive cellulitis and myositis. The patientFig. 6. The limb after placement of the VAC dressing.
here was extensive subcutaneous oedema noted. The surgery
nvolved circumferential debridement of fat necrosis and muscle
nd washout of his left leg wound (Figs. 4 and 5). The explored leg
as managed with a vacuum assisted closure (VAC) dressing (Fig. 6)
nd antibiotics were continued. The subcutaneous fat and fascia
as sent for microscopy, culture and sensitivity and histopatholog-
cal review. The cultures from the wound conﬁrmed A. baumannii.
He remained ventilated post operatively and was commenced
n a noradrenaline infusion due to hypotension despite ade-
uate ﬂuid resuscitation. Cultures from the left leg subcutaneous
issue conﬁrmed a light growth of A. baumannii resistant to
moxicillin, augmentin, ceftriaxone and ceftazidime and sensi-
ive to co-trimoxazole and gentamicin. After an infectious disease
hysician consult, his antibiotic regime was changed to intra-
enous ciproﬂoxacin, meropenem and lincomycin. Vancomycin
as ceased as blood cultures for MRSA and Vancomycin-Resistant
nterococci (VRE) were negative.
Further surgical debridement was performed 6 days later and
he surgical ﬁndings revealed necrotic circumferential subcu-
aneous fat. At surgery circumferential debridement of all the
ubcutaneous tissue in the left lower leg was performed. There was
xtensive washout of this area with hydrogen peroxide and a new
AC dressing was  applied. Histopathology of the left leg subcuta-
eous fascia revealed epidermal and dermal infarction with focal
at necrosis and acute inﬂammation. There was no histological evi-
ence of fasciitis and his antibiotic management was  tailored to
ntravenous meropenem and ciproﬂoxacin.
During his admission there were two further surgical proce-
ures performed primarily to change the VAC dressing. Thirteen
ays after admission further exposure of the wound revealed that
he wound was clean but there were still areas of necrosis along
he wound edges. Minor debridement was performed and the VAC
ressing replaced. Sixteen days after admission the VAC dress-
ng was again replaced and the wound reviewed. It was noted
hat there was signiﬁcant improvement but still small areas of
ecrotic tissue both proximally and distally. There were areas of
ecrotic tissue attached to the fascia but all the musculature was
iable. A further minor debridement was performed with removal
f small areas of necrotic tissue and fascia. Samples were sent for
icroscopy, culture and sensitivity and the wound was  washed
ith hydrogen peroxide. During the latter two weeks of his admis-
ion he became clinically jaundiced with worsening hepatic and
enal function and his condition continued to deteriorate despite
ppropriate antibiotics and surgical interventions and he devel-
ped hepatic, circulatory, respiratory and haematological failure.PEN  ACCESS
ry Case Reports 5 (2014) 532–536
During the patient’s admission his blood glucose levels ﬂuctuated
between 4 and 8 mmol/l apart from a 24 h period when he was
signiﬁcantly inotrope dependent and had a single glucose reading
of 10 mmol/l requiring insulin. Three weeks after this initial pre-
sentation, he continued to require signiﬁcant vasopressor support
and signiﬁcant tissue from the lower limbs had been lost. The deci-
sion by the intensive care and surgical teams was that in light of
his co-morbidities and worsening multiple organ failure ongoing
medical care constituted medical futility and a decision was made
to palliate.
3. Discussion
Our case highlights the fact that A. baumannii can cause fatal
soft tissue infections. Whilst A. baumannii infections were ini-
tially found to be non-fatal, there are an increasing number of
reports conﬁrming increased mortality and morbidity associated
with multi drug resistant Acinetobacter infections.5 The case we
present shows similarity with other case reports of A. baumannii
infection published in literature.
The incidence of multi drug resistant Acinetobacter infections
is increasing. In Australia, the ﬁrst report of a hospital acquired
drug resistant A. baumannii strain within an intensive care unit
was in 1996 from Western Australia.6 Since then there has been
an emergence of carbapenem resistance in A. baumannii recovered
from blood cultures in Australia.7 A recently published study under-
taken by Marshall et al., 8 within three major teaching hospitals in
Melbourne found the rate of colonization of ICU patients with Acine-
tobacter spp. to be steadily rising from an estimated 3–5 percent
over its ﬁve year duration.
Over the last few decades is has been noted that many strains
of A. baumannii have developed resistance to many currently avail-
able antibiotics and the mechanisms involved with this multi-drug
resistance have been extensively described by Fournier et al.9
This research suggested the acquisition of genetic material was
responsible for the rapid development of these strains to display
multi drug resistance. This genetic material carried clusters of up
to 52 distinct genes involved in encoding both enzymatic and
non-enzymatic resistance to several antibiotic families at once –
including anti-pseudomonal carbepenems and cephalosporins, ﬂu-
oroquinolones and aminoglycosides.
Reﬂecting this rapid rise in antimicrobial resistance, a sys-
tematic review conducted by Falagas5 suggested an increase in
mortality in patients who  acquired A. baumannii when compared
with matched controls without acquisition. Despite reports of SSTI
caused by A. baumannii in war  trauma patients,10 its role in non-
traumatic SSTI is not well deﬁned.4 A. baumannii is being recovered
more frequently in association with SSTI.4
Managing Acinetobacter infections remains difﬁcult due to the
array of resistance and the pathogens ability to develop new and
ongoing resistance.11 Antimicrobial agents that are typically active
against Acinetobacter infections are the carbepenems, amikacin,
sulbactam, colistin, rifampicin and tetracyclines. In the setting of
broad spectrum antimicrobial resistance, colistin usually retains
activity despite it being considered by some to be overly neuro
or nephrotoxic for routine clinical use. Colistin in association with
rifampicin appears to be relatively safe and effective in treating
critically ill patients with infections caused by multidrug-resistant
A. baumannii.12
In the case presented, A. baumannii colonization of the
superﬁcial pre-tibial abrasions on the patient’s left leg resultedunder discussion had several risk factors including chronic
liver disease and morbid obesity. Although he had been treated
initially on empirical broad spectrum antibiotics, blood cultures
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evealed MDR  A. baumannii,  that was resistant to his initially pre-
cribed antibiotics. Despite more targeted antibiotic therapy and
urgical debridements he continued to deteriorate and developed
ultiple organ failure that eventually led to his death.
A wide range of other pathogens such as Nocardia, atypical
ycobacteria (M.  fortuitum, M.  marinum, M.  ulcerans), Sporothrix,
ryptococcus, agents of mycetoma (Pseudallescheria, Blastomyces,
hialophora) and Leishmania cause unusual skin and soft tissue
nfections.
Relapsing or persisting skin and soft tissue infections after injury
ith biological materials should also prompt consideration of other
athogens including atypical mycobacteria, even in non-immune
ompromised hosts. Insidiously, Mycobacterium marinum infection
an occur without any contact to ﬁsh tanks or swimming pools.
here have been case reports of patients with arthritis receiv-
ng immunosuppressive therapy who have been infected with
typical mycobacteria. One patient developed a granulomatous
nfection of the right thumb and forearm due to M. marinum and
as successfully treated with clarithromycin and ethambutol.13
here have also been cases of atypical soft tissue infection after
osmetic surgery. A case of Mycobacterium chelonae infection in
he buttock after combined liposuction and lipoinjection has been
escribed.14 The real possibility of contamination from operating
oom equipment was the potential etiologic factor of this infec-
ion. The difﬁculty conﬁrming the diagnosis was solved by speciﬁc
ulturing techniques. Successful treatment with limited debride-
ent and irrigation combined with prolonged speciﬁc antibiotic
herapy effected a long-term cure. Non-tuberculous mycobacterial
kin infections have an increasing incidence and in immunocom-
etent patients, they usually follow local trauma. There have been
eports of cutaneous Mycobacterium abscess infection following
esotherapy where the lesions were successfully treated with a
ombination of clarithromycin, ciproﬂoxacin, and doxycycline.15
nother rare cause of soft tissue infection and necrotizing fasciitis is
nfection with Vibrio vulniﬁcus. This occurs mostly in immunocom-
romised patients with hepatic disease, diabetes mellitus, chronic
enal insufﬁciency and adrenal insufﬁciency.16 The authors con-
lude that early and appropriate diagnosis for V. vulniﬁcus infection
hould be made, especially in patients presenting with atypical
linical ﬁndings and early fasciotomy within 24 h remains the
ighest priority and decreases mortality. A further rare cause of
kin and soft tissue infection is the pathogen Clostridium sep-
icum and an association exists between colon carcinoma and C.
epticum infection, especially bacteremia.17 The diagnosis of soft
issue infection remains difﬁcult and the assessment of wound ﬂuid
actate concentration might be helpful for conﬁrming the suspi-
ion of soft tissue infection, particularly when clinical signs are
typical.18 Atypical mycobacterial skin infections are difﬁcult to
iagnose due to their non-speciﬁc histopathology and presence of
ew bacteria. Therefore, these infections are often not recognized.
here is data to suggest that real-time PCR is useful in detecting
ycobacterial infections in undiagnosed formalin-ﬁxed/parafﬁn-
mbedded skin samples and that the application of molecular
pproaches would improve the diagnoses of mycobacterial skin
nfections.19 Atypical mycobacterial infections should be suspected
n patients who develop late-onset skin and soft tissue infection
fter cutaneous injury, injection, and surgical intervention, partic-
larly if they do not respond to conventional antibiotic treatment.
he lesions are often successfully treated with a combination of
larithromycin, ciproﬂoxacin, and doxycycline. In patients with
omplicated skin and skin structure infections there is evidence
hat tigecycline is as effective as vancomycin plus aztreonam. Fur-
hermore limited evidence shows effectiveness in patients with
esistant Acinetobacter infection in intensive care units, and the
ossibility that the use of tigecycline may  reduce length of hospital
tay.20PEN  ACCESS
ry Case Reports 5 (2014) 532–536 535
The surgical management of the patient was aggressive with
a total of 4 procedures during his hospital admission with
histology and repeated microbiology obtained to guide antimi-
crobial therapy. Despite subsequent VAC dressing changes and
clinical improvement of the wound with minimal necrosis the
patient continued to deteriorate. The worsening multiorgan fail-
ure despite ongoing source control suggests overwhelming sepsis
with progression to severe sepsis and septic shock. This response
to infection would be consistent with the patients conﬁrmed
liver cirrhosis. A review of patients with complicated skin and
soft tissue infections (cSSTI) conﬁrmed susceptibility in patients
with co-morbidities (42.6%), prior surgical intervention (43.4%),
more severe infections such as bacteraemia (51.6%) affected
fascia (49.0%) and in patients admitted to intensive care unit
(56.2%).21 Despite sonography being a frequent initial investigation
a study has found no signiﬁcant correlation between ultrasound
ﬁndings and clinical management in patients with soft tissue
infections.22 The early diagnosis of necrotizing soft tissue infec-
tion is challenging, but the key to successful management of
patients with necrotizing soft tissue infection are early recognition
and complete surgical debridement. Early initiation of appropriate
broad-spectrum antibiotic therapy must take into consideration
the potential pathogens. Critical care management such as the
initial ﬂuid resuscitation, end-organ support, pain management,
nutrition support, and wound care are all important aspects of
the care of patients with necrotizing soft tissue infection. Soft tis-
sue reconstruction should take into account both functional and
cosmetic outcome.23
Importantly in patients with necrotizing soft tissue infection, a
delay of surgical treatment of >12 h is associated with an increased
number of surgical debridements and higher incidence of septic
shock and acute renal failure.24 Because aggressive radical debride-
ment of all poorly perfused tissue is required, patients frequently
suffer from massive skin defects, which often requires autograft
skin grafting or myocutaneous ﬂaps. However, options are limited
in patients with limited autograft donor availability, or question-
able underlying wound bed viability. There have been reports
of synthetic devices leading to favourable outcomes when large
wound defects exist.25 Our patient had alcoholic liver disease with
cirrhosis and morbid obesity that may  have predisposed him to
Acinetobacter infection. Cirrhosis is considered an immunocompro-
mised state that leads to a variety of infections, which then account
for an approximate 30% mortality.26 Cirrhosis-associated immune
dysfunction syndrome (CAIDS) is a multifactorial state of systemic
immune dysfunction which decreases a patient’s ability to clear
to clear cytokines, bacteria, and endotoxins from circulation. Fur-
thermore porto-systemic shunting, whereby blood is increasingly
directed away from the liver, and reduced RE cells in patients with
cirrhosis, allow less bacteria and endotoxins to be cleared by the
liver from circulation.26 Monocyte spreading, chemotaxis, bacte-
rial phagocytosis, and bacterial killing are signiﬁcantly reduced
in cirrhosis compared with controls. Patients with cirrhosis have
decreased neutrophil mobilization and phagocytic activity, a phe-
nomenon that correlates with severity of liver disease.27 Chronic
oedema and increased bacterial translocation predispose patients
with cirrhosis to soft tissue infections, which constitute approxi-
mately 11% of infections.28 Necrotizing fasciitis is predominantly
caused by gram-negative bacilli.29 Necrotizing fasciitis in cirrhotic
patients rarely develops from an obvious portal of entry in the
extremities suggesting a potential pathway of bacterial translo-
cation and bacteremia leading to soft tissue infections.30 Broad
spectrum antibiotic treatment is essential in managing patients
with soft tissue infections complicating liver cirrhosis and they are
invariably resistant to therapy as a consequence of the described
pathophysiology. Surgical intervention for deep infections may
be needed and multiple interventions are often required in these
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rofoundly immune compromised patients. In spite of adequate
anagement the mortality remains high.
. Conclusion
A. baumannii is emerging as an important cause of severe, life-
hreatening cellulitis and other SSTI and may  be associated with a
igh mortality despite early aggressive and appropriate treatment.
STI in patients with pre-existing immunocompromised state such
s cirrhosis may  carry a very high mortality in spite of aggressive
nd appropriate management.
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